Atlas Trials

The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis

Clinical trial NCT03314831 · COMPLETED

Trial details

NCT number
NCT03314831
Sponsor
Charles University, Czech Republic
Status
COMPLETED
Study type
OBSERVATIONAL
Sepsis SyndromeSystemic Inflammatory Response Syndrome
Start date
2017-10-24
Primary completion
2021-12-31
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.